Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...
Steatotic liver disease, formerly known as fatty liver disease, is common, and it can lead to cirrhosis, liver cancer and the need for a liver transplant. The challenge is that different causes of ...
The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized oncology. However, a significant proportion of patients ...
As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...
AWS Social Impact and Sustainability Program awards Admera Health, Bringing Next-Generation Genomics to Underserved ...
MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that ...
Using single-cell sequencing and spatial tools, researchers have created the most comprehensive map of the maternal–fetal interface yet.
Boots No7 has developed the new 'time freezing' anti-ageing range alongside the University of Manchester, targeted at those in their 30s, with visible ageing accelerating by up to 50% during this peri ...
NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100K proteomics project. In this role, NovogeneAIT Genomics will process and generate data from ...
AutoNorm technology to optimize PCR amplification in real time, improving data quality and eliminating variability in ...
Vietnam Investment Review on MSN
Portrai presents 11 AI spatial transcriptomics posters at AACR
SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the ...
The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results